Cite
HARVARD Citation
Chretien, A. et al. (n.d.). Optimization of routine KRAS mutation PCR‐based testing procedure for rational individualized first‐line‐targeted therapy selection in metastatic colorectal cancer. Cancer medicine. pp. 11-20. [Online].